|
- 积分
- 1334
- 威望
- 1334
- 包包
- 4744
|
实在想做，可以看这里* q% y6 B+ p( V( `& a% _, Y
http://clinicaltrials.gov/ct2/re ... +cord+AND+stem+cell
- q9 h, a u* J. m! N3 bFound 57 studies with search of: spinal cord AND stem cell
- O2 ^) ^& C% VHide studies that are not seeking new volunteers.
( K; z W( q2 r8 THide studies with unknown recruitment status. Display Options Rank Status Study y( s# ]- C( }
1 Recruiting Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury Condition: Spinal Cord Injury
* @. Q9 R) m; q( g5 b- YIntervention: Procedure: Stem Cell Transplantation
* V2 M( X# }+ M
, d$ ?2 j/ h9 i R4 D A2 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis 0 @, _$ @/ F: P! K; Y; Y+ r
Intervention: Procedure: surgical implantation
, [% l. K* Z3 C" K/ [ V
# Y. E* }5 p3 A5 n, F' z3 [6 H3 Recruiting Autologous Stem Cells for Spinal Cord Injury (SCI) in Children Condition: Spinal Cord Injury ' G2 |. F7 ^6 b7 B! X6 d" T
Intervention: Biological: bone marrow progenitor cells (BMPC) autologous transplantation 6 E! p7 U, c' n% j! Q5 }
. Q" @8 K8 C+ @2 [+ d" t. ^/ c: }, e4 Active, not recruiting Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury Condition: Spinal Cord Injury
! T; L3 M. b4 E- \, dIntervention: Biological: autologous mesenchymal stem cells
- B9 D& B5 u2 g8 s! `* A* P J
, R6 R5 g+ U% I. z' R1 F# C3 M* R5 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Conditions: Spinal Cord Injury Thoracic; Spinal Cord Injury " t! m% F) a2 F' s5 u4 p; i# p
Intervention: Procedure: HuCNS-SC cells
( {1 K/ P! @8 `
0 X8 F, @6 A4 A/ m8 a( W6 Completed Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury Condition: Spinal Cord Injuries
" I/ ?8 e8 h( j0 Z% N4 ]Interventions: Procedure: laminectomy; Procedure: Intrathecal
: S& _) R3 \8 `- j5 B 5 J8 j# w* z& h. Q& B
7 Completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma 6 N+ U- U9 O2 s+ w$ x5 i
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: thiotepa; Drug: vincristine sulfate; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation
4 Y2 I5 s& _6 L7 K& @' [ 2 j) E2 s/ c& U/ U) D) b
8 Completed Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. Condition: Spinal Cord Injury ; a, x* J' \. _) R" }- w
Intervention: Other: Autologous Adipose Derived Mesenchymal Stem Cells
6 p- V4 u! X1 k, m! Y9 i
3 L0 S8 C+ s( [3 b( u+ k4 a) L# Y9 Recruiting Bone Graft Materials Observational Registry Conditions: Degenerative Disc Disease; Herniated Disc; Spinal Stenosis; Spondylolithesis; Spinal Deformity; Cervical Myelopathy; Failed Back Surgery Syndrome; Spinal Cord Neoplasms
8 g8 p/ v' _3 W N6 TIntervention: Device: Bone growth substitute, autograft or allograft : c: \0 e/ k, f6 f1 Z3 l
7 V2 ~+ O/ \) _- E, _" ^5 B' _* v4 I
10 Recruiting Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy Condition: Autoimmune Disorder
4 x0 x) p1 B4 I: s5 K9 nInterventions: Biological: anti-thymocyte globulin; Drug: carmustine; Drug: cytarabine; Drug: etoposide; Drug: melphalan; Drug: prednisone; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: syngeneic bone marrow transplantation; Other: laboratory biomarker analysis
" b+ ]; N4 D# U' ?6 ?
% r' _3 J8 u- E- `, O# G; o1 b11 Active, not recruiting Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Condition: Multiple Sclerosis 9 v Q) G4 Z2 z' T0 @, J: R
Intervention: Procedure: hematopoietic stem cell transplantation 4 v, ?5 \2 d8 ^& Y" T) w# f5 d
# a4 y& u- c* S4 q, G( W. t' X% y12 Recruiting Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica Condition: Neuromyelitis Optica (NMO) ! q7 N% T( F9 j( ?6 |$ N
Intervention: Procedure: AHSCT : B6 e, n1 x5 e/ A& y8 X0 r$ A$ n
: K) w) @ S1 A, H
13 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Condition: Multiple Sclerosis
/ L3 Q; U, d6 hInterventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant 4 b( k# c' A0 g" ]
& b: N2 i$ Q: {14 Completed Cell Transplant in Spinal Cord Injury Patients Condition: Chronic Spinal Cord Injury
5 P$ I" x. D" W- `% f) S2 XInterventions: Procedure: Autologous bone marrow transplant; Procedure: Physical therapy
6 Z/ K+ a+ X+ {1 d& A2 J5 h8 d
3 @8 C2 ?( r2 R6 k1 t15 Active, not recruiting Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic 0 I7 C$ \# h1 t/ q) n; ~1 Q) t
Interventions: Drug: fludarabine phosphate; Drug: cyclophosphamide; Biological: Rituxan (rituximab); Biological: filgrastim; Drug: methylprednisolone; Other: immunologic technique; Other: laboratory biomarker analysis; Procedure: autologous hematopoietic stem cell transplantation : }! k7 @) q6 T. V+ t& y( z, X
( v/ i* V5 Q5 M9 a16 Unknown † Mesenchymal Stem Cells for the Treatment of MS Condition: Multiple Sclerosis
1 S' K; `+ C6 U* TIntervention: Biological: injection of autologous stem cells
3 q+ G$ O. M) M: X8 V8 o% L # `% W2 }* `# t2 i3 L. X2 s
17 Recruiting Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Condition: Lymphoma
, B K$ M3 [! y" B+ BInterventions: Drug: carmustine; Drug: cyclophosphamide; Drug: etoposide; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy; Biological: G-CSF 2 j/ ?7 W5 ?, C* {! w
" J7 n/ m0 U. w5 ]& d18 Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Condition: Sarcoma . |2 B# o* @* }; } B: p
Interventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy
' D: E8 l* Q: y$ E+ x5 m ' G3 c/ Z' d" \
19 Recruiting Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) Condition: Amyotrophic Lateral Sclerosis ) s" f6 d, K( C5 L8 I
Interventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Intrathecal infusion of autologous bone marrow stem cells; Procedure: Intrathecal infusion of placebo (saline solution). " S v. q7 M) P' M6 l
9 c/ v4 c J! h! f# F0 b2 j7 E20 Active, not recruiting Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma Condition: Neuroblastoma : F+ T1 x" m, v6 X$ Q$ A
Interventions: Drug: Cisplatin and Etoposide; Drug: Adriamycin and Cyclophosphamide " t% [( t. n/ \4 i: Y7 v. S, h, |
; e6 G9 C$ z7 E9 VFound 57 studies with search of: spinal cord AND stem cell
% m O# y8 A1 k: C4 l6 j# uHide studies that are not seeking new volunteers.4 Z: v$ r) h8 n5 s' @* a
Hide studies with unknown recruitment status. Display Options Rank Status Study - Q3 J/ T& d9 v0 N# y
21 Completed Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis ; P; x- w" h$ c X9 g+ X
Interventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Autologous bone marrow cells collection 3 u7 [$ v; |* `, z( r4 k) u; l; W
+ W6 `1 Z% o3 y4 D1 M
22 Active, not recruiting Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis
; Z5 D8 p+ X- [$ c" L( b: B; A9 c. lIntervention: Biological: autologous mesenchymal stem cells
* x& G3 k! M E4 \, _& x! x; d
9 Y5 T m, Y% E( a) e$ }! H8 V23 Active, not recruiting Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis 1 ^/ Q/ M! F+ a" v( }
Intervention: Biological: autologous bone marrow-derived stem cells
, @! \( q# Y# |: x( G
5 S( r+ D5 J3 w9 K* f- P& m24 Unknown † Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis
8 ]3 `+ a8 l# k- b+ cIntervention: Drug: Cistanche Total Glycosides
2 n' U- j4 u) s0 j; P
7 M6 q8 c9 s- v8 B25 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis
) y" T0 Z O8 a4 X9 ^( q% n5 @Interventions: Drug: Granulocyte Colony Stimulating Factor; Drug: NS % B* i5 z3 i2 V4 }* j
2 p9 O; o% i v' V" C
26 Active, not recruiting Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells Condition: Amyotrophic Lateral Sclerosis
: M2 U' z# R0 ~8 ^Intervention: : @9 P( I# K$ I c2 g4 V; `
1 z- ?; i" ~. l6 {! h3 W' @27 Not yet recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. Condition: Amyotrophic Lateral Sclerosis
z% o0 q/ K5 eInterventions: Biological: MSC-NTF cells transplantation (i.m.); Biological: MSC-NTF cells transplantation (i.t.)
4 \3 @& Q9 h# H; ~% C6 h2 l ! ?( ~% E. ?* ~' m- G( Y" B, }
28 Active, not recruiting Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis - T; I. f: F" z
Intervention: Drug: SB-509 % ~# w, M, X/ [. p7 G$ }) o$ H2 E
- ~' R0 @" ^ V8 O/ O0 z
29 Active, not recruiting Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Extra-adrenal Paraganglioma + R# d. [# D' z y
Interventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study 9 H5 g' v3 X2 ]# _3 m
5 h5 R) E0 x! V7 w7 ~. O( _- ]3 i3 j
30 Active, not recruiting Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
' {) h: c2 |, _' N4 j M3 f4 I$ P5 dInterventions: Drug: carboplatin; Drug: tamoxifen citrate; Drug: topotecan hydrochloride; Other: pharmacological study 9 {) w; P6 K( }+ h" T4 Z4 ~+ Z
8 u' g/ P* g9 r/ l" R- K31 Recruiting Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia Condition: Critical Limb Ischemia
: z6 U: J0 B) [$ p' G$ ZIntervention: Biological: Cord blood stem cell injection 4 E, g4 n/ y* j2 T
3 @: Q$ K# C m y/ ` |
|
发表于 2011-5-21 11:11
。。。。可否提供中文的信息，谢谢。* n& g* S# O# _ U. H9 B9 n4 E. @
我看看先，看看有没有可行性的方案。